Sign In
Buy MRMD
$0.0799
+0.0002 (+0.301%)
At Close: Jun 03, 2026
MariMed Inc. (MRMD) Q1 2026 Earnings Call Transcript
10:05am, Thursday, 14'th May 2026
MariMed Inc. (MRMD) Q1 2026 Earnings Call Transcript
MariMed Inc. (MRMD) Reports Q1 Loss, Beats Revenue Estimates
07:26pm, Wednesday, 13'th May 2026
MariMed Inc. (MRMD) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago.
MariMed Reports First Quarter 2026 Earnings
05:00pm, Wednesday, 13'th May 2026
NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every d
MariMed Announces First Quarter 2026 Earnings Date
05:00pm, Wednesday, 15'th Apr 2026
NORWOOD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announc
MariMed Inc. (MRMD) Q4 2025 Earnings Call Transcript
11:42am, Thursday, 12'th Mar 2026
MariMed Inc. (MRMD) Q4 2025 Earnings Call Transcript
MariMed Reports Fourth Quarter and Full Year 2025 Earnings
05:05pm, Wednesday, 11'th Mar 2026
NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every
MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure
04:15pm, Monday, 02'nd Mar 2026
NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announc
MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date
07:30am, Wednesday, 11'th Feb 2026
NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announce
MariMed (OTCMKTS:MRMD) versus Brainsway (NASDAQ:BWAY) Head-To-Head Review
01:08am, Monday, 09'th Feb 2026
Brainsway (NASDAQ: BWAY - Get Free Report) and MariMed (OTCMKTS:MRMD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies bas
MariMed Statement on Historic Rescheduling of Cannabis
01:52pm, Thursday, 18'th Dec 2025
NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the fol
Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries
05:00pm, Monday, 08'th Dec 2025
Veteran and customer of Thrive Dispensary in Anna, IL writes song of appreciation for Thrive and to raise visibility for veteran's org FreedomSingsUSA.
MariMed's Betty's Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's
07:30am, Tuesday, 18'th Nov 2025
Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit Chew to Deliver Cozy Winter Wind-Downs Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit C
MariMed Inc. (MRMD) Q3 2025 Earnings Call Transcript
02:26pm, Thursday, 06'th Nov 2025
MariMed Inc. (OTCQX:MRMD) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Anna Massanari Jon Levine - Co-Founder, CEO, President, Secretary, Treasurer & Director Ryan Crandall
MariMed Inc. (MRMD) Reports Q3 Loss, Misses Revenue Estimates
08:36pm, Wednesday, 05'th Nov 2025
MariMed Inc. (MRMD) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to break-even earnings per share a year ago.
MariMed Reports Third Quarter 2025 Earnings
05:00pm, Wednesday, 05'th Nov 2025
NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every
